Toll-Like Receptor 4 Mediates Endothelial Cell Activation Through NF-kappa B but Is Not Associated with Endothelial Dysfunction in Patients with Rheumatoid Arthritis

作者：Menghini Rossella; Campia Umberto^*; Tesauro Manfredi; Marino Arianna; Rovella Valentina; Rodia Giuseppe; Schinzari Francesca; Tolusso Barbara; di Daniele Nicola; Federici Massimo; Zoli Angelo; Ferraccioli Gianfranco; Cardillo Carmine

来源：PLos One, 2014, 9(6): e99053.

DOI：10.1371/journal.pone.0099053

Objective: To investigate the effects of TLR4 antagonism on human endothelial cells activation and cytokine expression, and whether the Asp299Gly TLR4 polymorphism is associated with better endothelial function in patients with rheumatoid arthritis (RA). %26lt;br%26gt;Methods: Human aortic endothelial cells (HAECs) were treated with lipopolysaccharide (LPS), OxPAPC, and free fatty acids (FFA) at baseline and after incubation with the TLR4 antagonist eritoran (E5564). Cytokine expression was assessed by quantitative real-time PCR. In vivo endothelial function was assessed as brachial artery flow-mediated dilation (FMD) in RA patients with the wild type gene (aa) and with the Asp299Gly TLR4 polymorphic variant (ag). %26lt;br%26gt;Results: In HAEC, TLR4 antagonism with eritoran inhibited LPS-induced mRNA expression of IL-6, IL-8, TNF alpha, CCL-2, VCAM and ICAM (P %26lt; 0.05 for all) and inhibited Ox-PAPC-induced mRNA expression of IL-8 (P %26lt; 0.05) and IL-6, albeit not to a statistically significant level (p = 0.07). In contrast, eritoran did not affect FFA-induced mRNA expression of IL-6 (P %26gt; 0.05). In 30 patients with RA (15 with the ag allele) undergoing measurement of FMD, no differences in FMD and plasma levels of IL6, IL-8, VCAM, and ICAM were found between the aa and the ag phenotype (P %26gt; 0.05 for all). %26lt;br%26gt;Conclusions: TLR4 signaling in endothelial cells may be triggered by LPS and oxidized phospholipids, leading to endothelial activation and inflammation, which are inhibited by eritoran. Our in vivo investigation, however, does not support an association between the Asp299Gly TLR4 polymorphism and improved endothelium-dependent vasodilator function in patients with RA. Further study is needed to better understand the potential role of TLR4 on endothelial dysfunction in this and other patient populations.

• 出版日期2014-6-11